Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Premier Partners aims to launch a KRW 200 billion bio fund, establishing its position as a top bio investor. The firm has recently obtained general partner status, strengthening its expertise in the health and bio sector.
PRIVATEAug 25, 2026•about 5 hours ago
Amount Raised
₩200 Million
Round Type
Pre-Seed
BiotechnologyHealth CareVenture Capital
Description
Premier Partners, a leading venture capital firm in Korea, is focusing on establishing a KRW 200 billion bio fund. This initiative follows the firm's recent designation as a general partner, enhancing its reputation in the bio investment sector. With over a decade of experience, the firm aims to capitalize on the growing bio market. The dedicated Bio Division plays a crucial role in this strategic direction.
Company Information
Company
Premier Partners
About
Premier Partners is Korea's first domestic limited liability company (LLC)-type venture capital firm, established to focus on health and biotechnology. With over a decade of expertise, it has built a dedicated Bio Division that aims to launch a KRW 200 billion bio fund. The firm specializes in investing in domestic biotechnology and healthcare companies, particularly those dealing with innovative technologies related to vaccines.
Don't miss Premier Partners's next move
Get an email the moment Premier Partners raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Premier Partners's next move